t before becoming CEO-elect in 2025. Learn more about Julie’s experience and leadership roles on Takeda.com.

To help guide Takeda’s next growth chapter, shareholders elected members of the Board of Directors, including three new external directors: Bruce Broussard, Koichiro Kimura and Dr. Paul Stoffels.


Mr. Broussard brings decades of leadership experience with large global companies and international business management, and deep expertise in the U.S. healthcare system.

As the former Chairman of PricewaterhouseCoopers in Japan, Mr. Kimura has extensive experience in geopolitical risk and corporate governance across the Asia-Pacific region.

Dr. Stoffels brings an exceptional track record in pharmaceutical R&D innovation, having overseen the global launch of 25 medicines, first as Chief Science Officer at Johnson & Johnson, and then as CEO of biotechnology company Galapagos.


At the Board of Directors a
=*=*=*=*=*=
当前为第4/15页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页